MYRIAD GENETICS, INC. AND SUBSIDIARY
		    CONSOLIDATED STATEMENTS OF OPERATIONS
				   Years Ended June 30,
				    1996	    1995
REVENUES
	Research revenue $6,628,624    $1,294,500
 Net Loss		 (5,897,473)   (5,268,383)
 Net loss per share	 $(0.78)	 $(1.19)
Weighted average shares
  outstanding	     7,608,548     4,427,095